[#item_full_content]
Merck snags Chinese obesity drug in nearly US$2 billion deal
2024-12-19T00:01:07-05:00December 19th, 2024|
Related Posts
-
Asia dealmakers see more IPOs, convertible bonds in 2025
December 19th, 2024 -
Latest Singapore six-month T-bill cut-off yield inches up to 3.02%
December 19th, 2024 -
South Korea pension fund, central bank expand FX swap line as won drops
December 19th, 2024 -
Indonesian arm of Malaysia’s Mr DIY drops on market debut
December 19th, 2024